Skip to main content
. 2020 Jan 23;19(3):2413–2421. doi: 10.3892/ol.2020.11343

Figure 1.

Figure 1.

Immunoexpression of β-catenin and E-cadherin in thymomas type (A and B) A, (C and D) B1 and (E and F) non-invasive type B2 (cytoplasmic expression), in (G and H) invasive thymomas type B2 and in (I and J) type B3 (membranous expression).